Abstract:Amyloid pathology is thought to accelerate tau propagation via neuronal connections in individuals at high risk for Alzheimer's disease (AD). Carriers of AD-causing mutations have elevated levels of amyloid pathology several years before tau accumulation. We hypothesized that the earliest tau pathology will be associated with connectivity abnormalities in the uncinate fasciculus, a tract innervating the entorhinal cortex. Further, we examined the association between white matter abnormalities, age and cognitive performance. 15 non-demented carriers from the Colombian-kindred (age range =28-45 years, Figure 1) underwent PiB-PET, Flortaucipir- FTP PET, diffusion tensor imaging (DTI) and memory testing (CERAD Word List Learning). The DTI-data were processed with TRACULA (FreeSurfer), tract of interest was the uncinate fasciculus (UF) and the control tract was the angular cingulum bundle (CB). Regional FTP was measured in entorhinal (EC) and inferior temporal (IT, control region) cortices. PiB was measured in a neocortical aggregate region. We performed Spearman's rank correlations (also partialling out age) to investigate associations between tau, diffusion metrics and memory. Demographics of the carriers. Higher levels of left EC tau pathology were associated with higher axial diffusivity (AxD), higher mean diffusivity (MD) and higher radial diffusivity (RD) in the UF in the carriers (Figure 2). The associations for MD and RD remained significant after controlling for age (r=0.55,p=0.04; r=0.58, p=0.03 respectively). Spatial analyses showed that group differences in the relationship between EC tau and UF diffusion occurred close to the EC (Figure 3). No associations were found for the right side or the CB tract or IT tau (all p>0.05). Left UF diffusivity did not correlate with memory performance or MMSE scores (with or without controlling for age, all p>0.05). The association between entorhinal tau pathology and diffusion in the uncinate fasciculus in preclinical autosomal dominant Alzheimer's disease Note: the interaction group by EC tau pathology on tract diffusivity is plotted and statistical significance for the interaction is provided in the panels (corrected for age, robust regressions). Note the limited range in tau pathology in the non- carriers. Abbreviations: FA = Fractional Anisotropy, MD = Mean Diffusivity, AxD = Axial Diffusivity, RD = Radial Diffusivity, EC = Entorhinal cortex, UF = uncinate fasciculus spatial distribution of the group differences of the association between entorhinal tau pathology and uncinate fasciculus diffusivity Note: for each voxel along the center of the tract, we plotted the p-values (see scale bar) for the Spearman's rank correlations between entorhinal tau and mean diffusivity of the uncinate fasciculus in carriers. Red/orange voxels indicate where the interaction was significant at p< 0.05. Consistent with figure 2, we observed mostly left-sided effects. The sagittal plane view was slightly rotated along the z-axis for optimal viewing of the morphology of the tracts. These results suggest that EC tau pathology in PSEN1 E280A mutation carriers is associated with diffusion abnormalities in connected tracts, several years before clinical onset. They also suggest that tau may propagate via neuronal connectivity rather than proximity. Larger samples sizes, including a control group, will be necessary to investigate differences between carriers and non-carriers for the interaction between white matter and tau pathology on memory performance.

IC‐P‐140: TAU ACCUMULATION AND MEMORY DECLINE ARE MORE CLOSELY RELATED TO STRIATAL THAN CORTICAL AMYLOIDOSIS IN INDIVIDUALS WITH EARLY‐ONSET AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

Striatal Amyloid is Associated with Tauopathy and Memory Decline in Familial Alzheimer’s Disease

P4‐299: TAU ACCUMULATION IN THE ENTORHINAL CORTEX AND PRECUNEUS IS ASSOCIATED WITH CORTICAL AMYLOID‐BETA BURDEN, AGE AND WORSE MEMORY PERFORMANCE IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease

P3‐399: ASSOCIATION BETWEEN CORTICAL THINNING AND TAU PATHOLOGY IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

TAU ACCUMULATION IN RHINAL CORTEX IS ASSOCIATED WITH MEMORY PERFORMANCE IN NON-DEMENTED YOUNG ADULTS WITH AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

Associations between plasma p‐tau217, in vivo brain pathology and cognition in individuals with autosomal‐dominant Alzheimer’s disease: Findings from the Colombia‐Boston (COLBOS) biomarker study

P4‐269: Relationships Between Baseline Biomarkers and Subsequent Cognitive Decline in Cognitively Unimpaired PSEN1 E280A Mutation Carriers from the Colombian Kindred with Autosomal Dominant Alzheimer's Disease

ASSOCIATION BETWEEN CEREBRAL AMYLOIDOSIS AND WORSE COGNITIVE PERFORMANCE IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE: BASELINE FINDINGS FROM THE API COLOMBIA AUTOSOMAL DOMINANT AD TRIAL

RELATIONSHIPS BETWEEN MEMORY FUNCTION, TAU PATHOLOGY AND FUNCTIONAL CONNECTIVITY IN THE DEFAULT MODE NETWORK IN AUTOSOMAL-DOMINANT ALZHEIMER’S DISEASE: A PRELIMINARY REPORT

IC‐P‐017: Trajectory of Age‐associated Structural Changes in Early‐onset Alzheimer's Disease, for the Alzheimer's Prevention Initiative

P2‐461: ENTORHINAL TAU PATHOLOGY IS ASSOCIATED WITH WHITE MATTER ABNORMALITIES IN UNCINATE FASCICULUS IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease

Task-dependent Fmri Abnormalities in Young Adults at Genetic Risk for Early-Onset Alzheimer's Disease

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease

O1‐01‐04: Age‐associated Trajectories of Biomarkers in Early‐onset Alzheimer's Disease, for the Alzheimer's Prevention Initiative

Amyloid‐β but not tau accumulation is strongly associated with longitudinal cognitive decline

PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers

Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.

Predictors of Cognitive Decline in Healthy Middle-Aged Individuals with Asymptomatic Alzheimer’s Disease

Connectome-based predictive modeling of brain pathology and cognition in Autosomal Dominant Alzheimer's Disease